-
Here's how movement can extend longevity and prevent disease
20 Apr 2024 05:37 GMT
… university classroom, that if drug companies could bottle up … extend longevity and prevent disease. Modern research has confirmed … a chronic condition such as arthritis. These specialists will be … properly for the body, it develops symptoms. And conversely, if …
-
FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies
19 Apr 2024 20:21 GMT
… FDA to treat moderate to severe plaque psoriasis and active psoriatic arthritis … provide more treatment options for patients.
The FDA approval … a clinical development program that included 2 trials: the randomized … the risk of disease recurrence or death …
-
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
19 Apr 2024 20:21 GMT
… psoriasis and active psoriatic arthritis in adults and … A clinical development program for the drug included data … ustekinumab.
READ MORE: FDA: Simlandi Becomes Third Interchangeable … treatment options for patients.
Alvotech is also working to develop …
-
Paradigm makes key submission to US FDA to advance osteoarthritis Phase 3 trial
19 Apr 2024 03:21 GMT
… trial to FDA for review and comment
Pending FDA … joint disease or ‘wear and tear’ arthritis, … developing injectable pentosan polysulfate sodium (iPPS/Zilosul) for the treatment … drug on a particular disease or condition.
The most advanced trials …
-
Study Investigates Optimal COVID-19 Vaccination Timing in Inflammatory Disease
19 Apr 2024 01:21 GMT
… arthritis (PsA), ankylosing spondylitis and spondyloarthritis, and inflammatory bowel disease … regressions, such as medication use, vaccination history, … lack of detailed drug exposure information hindered … to evaluate interactions between drugs, IMID type, …
-
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
18 Apr 2024 22:39 GMT
… controlled trials (RCTs) of 92 biologic therapies and 38 non-biologic treatments … ) receiving biologic treatment and 12,940 receiving placebo.
Of these trials, 96 … psoriatic conditions, such as psoriatic arthritis. Second, there was significant heterogeneity …
-
New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement
18 Apr 2024 21:38 GMT
… reduced risk of developing hip arthritis over the long … eventually progressing to advanced arthritis.
Prior studies have shown … difference in the natural development of arthritis between the operative … the potential of new drugs, therapeutics and devices. …
-
Phase 3 Upadacitinib Study Achieves Positive Results for the Treatment of Giant Cell Arteritis
18 Apr 2024 15:39 GMT
… to severe rheumatoid arthritis (RA), active psoriatic arthritis (PsA), … of this disease, with limited treatment options available … -mediated diseases by developing new treatments where significant medical … of continuing the drug compared with withdrawing …
-
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
18 Apr 2024 11:00 GMT
… for this devastating disease that has limited treatment options. ” … Del Galdo MD PhD, Arthritis Care & Research, … and complete clinical trials and achieve regulatory milestones … stage biotechnology company developing innovative therapeutics for …
-
ASX Health Stocks: Immutep hooks leading research firm CHDR to conduct Phase 1 drug study
18 Apr 2024 03:20 GMT
… with the Centre for Human Drug Research (CHDR) in the … cutting-edge early-stage clinical drug research – will perform a … will use a unique method developed by CHDR – the keyhole … for autoimmune disorders including rheumatoid arthritis, Type 1 diabetes, and …